menu close
www.latigobio.com

Latigo Bio Stock

Company Profile:

Latigo Bio is focused on developing innovative non-opioid pain medicines with best-in-class profiles. Their goal is to provide effective, rapid-acting pain relief by targeting pain at its source, without the risk of addiction.

Sign up for SecondMarket™ to view the market and buy or sell Latigo Bio Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Latigo Bio Management Team

  • Director

    Tim Walbert

  • CEO, Director

    Nima Farzan

  • CFO

    Tim Lugo

  • Director

    Deborah Palestrant

  • Director

    Nancy Stagliano

  • Director

    Kevin Raidy

  • Director

    Jim Tananbaum

  • Director

    Beth Seidenberg

Latigo Bio Major Investors

  • Access Biotechnology

  • Kern Capital

  • 5AM Ventures

  • Deep Track Capital

  • UPMC Enterprises

  • Rock Springs Capital

  • Cormorant Asset Management

  • Sanofi Ventures

  • Westlake Village BioPartners

  • Corner Ventures

  • Alexandria Venture Investments

  • Blue Owl Capital

  • Qatar Investment Authority (QIA)

  • Foresite Capital

Learn More About Latigo Bio Stock

Buy Latigo Bio Stock
01

Latigo Bio stock does not trade on public stock exchanges. Latigo Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Latigo Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Latigo Bio Stock
02

Latigo Bio Stock does not trade on public stock exchanges. In order to sell Latigo Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Latigo Bio Stock Price
03

Latigo Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Latigo Bio share price and other valuable private market data.

Read more about secondary market private company stock prices:

Latigo Bio Stock Ticker Symbol
04

There is no ticker symbol for Latigo Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Latigo Bio Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Latigo Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Latigo Bio Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Latigo Bio stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Latigo Bio Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Latigo Bio IPO
08

Latigo Bio is a private company and has not had an IPO. There is currently no Latigo Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Latigo Bio IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Latigo Bio Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Health

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Generate Biomedicines-Logo

Generate Biomedicines

Generative biology company with a revolutionary approach to drug development.

Tessera Therapeutics-Logo

Tessera Therapeutics

Genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.

Source: Nasdaq Private Market Tape D™